Defense Advanced Research Projects AgencyTagged Content List

Infectious Disease

Relating to ailments caused by pathogens

Showing 7 results for Disease + Syn-Bio RSS
DARPA’s Biological Technologies Office develops capabilities that embrace the unique properties of biology—adaptation, replication, complexity—and applies those features to revolutionize how the United States defends the homeland and prepares and protects its Soldiers, Sailors, Airmen, and Marines. BTO is helping the Department of Defense to counter novel forms of bioterrorism, deploy innovative biological countermeasures to protect U.S. forces, and accelerate warfighter readiness and overmatch to confront adversary threats.
09/18/2017
DARPA has enjoyed a strong relationship with Silicon Valley since the early 1960s, working with innovators to lay the groundwork for new industries built around Agency investments in semiconductors, networking, artificial intelligence, user interfaces, programming, materials, microsystems, and more. Biotech is now emerging as a breakthrough opportunity space and it represents an area that is ripe for fresh collaboration among DARPA, the nation’s top researchers, venture capitalists, and entrepreneurs.
Program Manager
Dr. Blake Bextine joined DARPA as a Program Manager in March 2016. He is interested in novel approaches to addressing issues facing agricultural biotechnology and biosecurity, including nucleic acid-based anti-pathogen/anti-pest strategies, insect and plant transformation strategies for rapid trait selection, and innovative approaches for altering insect behaviors.
Office Director
Dr. Brad Ringeisen was named Office Director of BTO in June 2019. He joined DARPA as the deputy director of BTO in December 2016.
Program Manager
Dr. Renee Wegrzyn joined DARPA as a Program Manager in 2016. She is interested in applying the tools of synthetic biology to support biosecurity and outpace infectious disease.